US$ 28.34
eli lilly glp-1 analog Lilly's $1 Trillion Boom: Inside Dave Ricks' Weight-Loss Bet GLP-1 pill race intensifies for
Description
Interesting new data from Gallup that deserves a closer look
Support your health while using Mounjaro, Wegovy, Ozempic or other GLP-1 medications

GLP-1s are shaking up the playbook and giving pharma companies a whole new set of moves to master

Blood thinners don't "thin" blood

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects

Ozempic vs Zepbound compared head-to-head: the SURMOUNT-5 trial shows tirzepatide (20.2%) beats semaglutide (13.7%) for weight loss
